Mairs & Power Inc Bio Techne Corp Transaction History

Mairs & Power Inc

$10.3 Billion
Q2 2024

A detailed history of Mairs & Power Inc transactions in Bio Techne Corp stock. As of the latest transaction made, Mairs & Power Inc holds 2,740,392 shares of TECH stock, worth $216 Million. This represents 1.91% of its overall portfolio holdings.

Number of Shares

2,740,392

Previous 2,959,357 7.4%

Holding current value

$216 Million

Previous $208 Million 5.74%

% of portfolio

1.91%

Previous 2.03%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$62.12 - $84.15 $13.6 Million - $18.4 Million	-218,965 Reduced 7.4%	2,740,392 $196 Million
Q1 2024 May 15, 2024	SELL	$65.98 - $77.09 $7.93 Million - $9.26 Million	-120,126 Reduced 3.9%	2,959,357 $208 Million
Q4 2023 Feb 14, 2024	BUY	$52.83 - $78.22 $1.37 Million - $2.03 Million	25,903 Added 0.85%	3,079,483 $238 Million
Q3 2023 Nov 14, 2023	SELL	$67.52 - $89.42 $409,036 - $541,706	-6,058 Reduced 0.2%	3,053,580 $208 Million
Q2 2023 Aug 14, 2023	BUY	$73.76 - $85.98 $2.48 Million - $2.89 Million	33,660 Added 1.11%	3,059,638 $250 Million
Q1 2023 May 15, 2023	BUY	$71.62 - $86.62 $15.4 Million - $18.6 Million	214,948 Added 7.65%	3,025,978 $224 Million
Q4 2022 Feb 14, 2023	BUY	$80.67 - $352.29 $172 Million - $753 Million	2,137,410 Added 317.3%	2,811,030 $233 Million
Q3 2022 Nov 14, 2022	BUY	$282.54 - $391.85 $5 Million - $6.93 Million	17,690 Added 2.7%	673,620 $191 Million
Q2 2022 Aug 15, 2022	SELL	$322.67 - $449.65 $655,665 - $913,688	-2,032 Reduced 0.31%	655,930 $227 Million
Q1 2022 May 16, 2022	BUY	$353.85 - $487.79 $1.47 Million - $2.02 Million	4,147 Added 0.63%	657,962 $285 Million
Q4 2021 Feb 14, 2022	SELL	$456.15 - $525.06 $4.02 Million - $4.63 Million	-8,819 Reduced 1.33%	653,815 $338 Million
Q3 2021 Nov 15, 2021	SELL	$444.87 - $538.88 $29.5 Million - $35.7 Million	-66,202 Reduced 9.08%	662,634 $321 Million
Q2 2021 Aug 16, 2021	SELL	$387.35 - $450.26 $16 Million - $18.6 Million	-41,199 Reduced 5.35%	728,836 $328 Million
Q1 2021 May 14, 2021	SELL	$314.62 - $411.0 $24.6 Million - $32.1 Million	-78,046 Reduced 9.2%	770,035 $294 Million
Q4 2020 Feb 16, 2021	SELL	$246.9 - $321.87 $1.8 Million - $2.35 Million	-7,302 Reduced 0.85%	848,081 $269 Million
Q3 2020 Nov 16, 2020	SELL	$232.22 - $282.96 $10.8 Million - $13.2 Million	-46,575 Reduced 5.16%	855,383 $212 Million
Q2 2020 Aug 14, 2020	SELL	$185.43 - $279.56 $22.6 Million - $34.1 Million	-121,991 Reduced 11.91%	901,958 $238 Million
Q1 2020 May 15, 2020	BUY	$161.17 - $221.51 $3.38 Million - $4.65 Million	20,997 Added 2.09%	1,023,949 $194 Million
Q4 2019 Feb 14, 2020	SELL	$189.68 - $222.09 $7.08 Million - $8.29 Million	-37,343 Reduced 3.59%	1,002,952 $220 Million
Q3 2019 Nov 14, 2019	SELL	$183.56 - $216.72 $5.11 Million - $6.04 Million	-27,851 Reduced 2.61%	1,040,295 $204 Million
Q2 2019 Aug 14, 2019	SELL	$188.72 - $215.43 $16.2 Million - $18.4 Million	-85,604 Reduced 7.42%	1,068,146 $223 Million
Q1 2019 May 15, 2019	SELL	$136.09 - $200.44 $4.98 Million - $7.34 Million	-36,612 Reduced 3.08%	1,153,750 $229 Million
Q4 2018 Feb 14, 2019	BUY	$132.75 - $203.8 $2.59 Million - $3.97 Million	19,487 Added 1.66%	1,190,362 $172 Million
Q3 2018 Nov 14, 2018	SELL	$147.44 - $204.11 $17.8 Million - $24.7 Million	-120,802 Reduced 9.35%	1,170,875 $239 Million
Q2 2018 Aug 14, 2018	SELL	$144.9 - $165.58 $12.6 Million - $14.4 Million	-86,670 Reduced 6.29%	1,291,677 $191 Million
Q1 2018 May 15, 2018	SELL	$131.46 - $151.04 $7.39 Million - $8.49 Million	-56,210 Reduced 3.92%	1,378,347 $208 Million
Q4 2017 Feb 14, 2018	SELL	$121.17 - $134.75 $1.2 Million - $1.34 Million	-9,923 Reduced 0.69%	1,434,557 $186 Million
Q3 2017 Nov 14, 2017	BUY	$113.59 - $123.78 $164 Million - $179 Million	1,444,480	1,444,480 $175 Million

Others Institutions Holding TECH

# of Institutions

604

Shares Held

153M

Call Options Held

171K

Put Options Held

56.9K

View Full List

About BIO-TECHNE Corp

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $3.09B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

More about TECH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mairs & Power Inc, based on Form 13F filings with the SEC.

News

Stay updated on Mairs & Power Inc with notifications on news.

Account